Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Fresenius SE & Co KGaA    FRE   DE0005785604

Real-time Quote. Real-time TRADEGATE AG - 04/24 09:54:28 pm
54.1060 EUR   +1.06%
04/16DJRhoen-Klinikum Proposes Higher Dividend, Further Buyback
02/25DJADR Shares End Mixed; National Bank of Greece, VimpelCom Trade Ac..
02/25DJDow Inches Up to a New Record
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Fresenius Sets Pricing On EUR500 Million 7-Year Bond At 4.25% Area

03/21/2012 | 07:24am US/Eastern

("Fresenius Sets Pricing On EUR500M 7-Year Bond At 4.25% Area," at 1020 GMT, misstated the vehicle issuing the bond in the first paragraph. The correct version follows:)

-German medical care company Fresenius SE & CO. KGaA (>> Fresenius SE & Co KGaA) has set price guidance on its EUR500 million seven-year bond in the area of 4.25%, one of the banks on the deal said Wednesday.

The issue will be priced later Wednesday, and books on the deal are comfortably oversubscribed, said one of the banks on the deal. The issue was primarily targeted at retail accounts, which showed a good deal of interest, it added.

The bond will be used--among other corporate purposes--to fund the acquisition of hospital operator Damp Group, which Fresenius acquired in October 2011.

Expected ratings are Ba1 from Moody's Investors Service and BB+ from Standard & Poor's Corp. and Fitch Ratings.

Royal Bank of Scotland Group PLC, Deutsche Bank AG, Commerzbank AG, LBBW and Bayern LB are lead managers on the deal.

-By Serena Ruffoni, Dow Jones Newswires; +44 (0) 207 842 9349; serena.ruffoni@dowjones.com

Stocks mentioned in the article : Fresenius SE & Co KGaA
React to this article
Latest news on FRESENIUS SE & CO KGAA
04/16DJRhoen-Klinikum Proposes Higher Dividend, Further Buyback
02/25DJADR Shares End Mixed; National Bank of Greece, VimpelCom Trade Actively
02/25DJDow Inches Up to a New Record
02/25 FRESENIUS SE KGAA : Sales and net income reach all-time highs – 6% dividen..
02/25 FRESENIUS SE KGAA : Medical Care reports fourth quarter and full year 2014 resul..
02/24DJFRESENIUS SE KGAA : 4Q 2014 -- Forecast
02/23DJFRESENIUS SE KGAA : 4Q 2014 -- Forecast
02/16 FRESENIUS SE KGAA : Kabi sells German oncology compounding business
02/16 FRESENIUS SE KGAA : Kabi sells German oncology compounding business
02/12DJPainkiller in Short Supply Following Hospira Recall -- Update
Advertisement
Chart
Duration : Period :
Fresenius SE & Co KGaA Technical Analysis Chart | FRE | DE0005785604 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF